Clinical Therapeutics

Aims & Scope

Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research.

In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors.

Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings.

Articles are indexed by all major biomedical abstracting databases.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.6
2024	3.20

SJR (SCImago Journal Rank)

Year	Value
2024	0.978

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	153

Journal Rank

Year	Value
2024	5005

Journal Citation Indicator

Year	Value
2024	1709

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A systematic review of the associations between dose regimens and medication compliance

  Citation: 1734

  Authors: Ami J., Joyce, Courtney

• Current Challenges in Cancer Treatment

  Citation: 744

  Authors: Jon, Cristiano, Santiago, Irene, Sonia, Luis

• Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice

  Citation: 641

  Authors: Kevin C.

• Capecitabine: A review

  Citation: 530

  Authors: Christine M., Celeste

• Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation

  Citation: 489

  Authors: Anastasia I., Smaro, Erifili, Julia M., Pio, Theoharis C.

• Childhood Obesity: A Review of Increased Risk for Physical and Psychological Comorbidities

  Citation: 484

  Authors: Elizabeth R.

• Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity

  Citation: 475

  Authors: Thomas N.

• The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma

  Citation: 473

  Authors: Kathleen M., Gordon J., David F.

• Immunogenicity of therapeutic proteins: Clinical implications and future prospects

  Citation: 457

  Authors: Huub

• Evaluating quality-of-life and health status instruments: development of scientific review criteria

  Citation: 440

  Authors: Kathleen N., Neil K., Jordi, M., Donald L., Edward B., James S.

---